The global Drugs for External Use market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Drugs that are used on the body surface or on certain mucous membranes to kill insects and relieve itching, reduce swelling and dissipate stagnation, dissipate putrefaction and discharge pus, promote muscle growth and mouth opening, and astringe and stop bleeding are called external medicines.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Drugs for External Use market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drugs for External Use market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Drugs for External Use market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Drugs for External Use market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Drugs for External Use market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drugs for External Use
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drugs for External Use market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yunnan Baiyao, Linrui, Cheezheng, Shengyang Hongyao, Yulin, Huahong Pharma, LKF, Hubiao, GSK, Tianhe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Drugs for External Use market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Lotion
Ointment
Tincture
Other
麻豆原创 segment by Application
Hospital
Clinic
Other
Major players covered
Yunnan Baiyao
Linrui
Cheezheng
Shengyang Hongyao
Yulin
Huahong Pharma
LKF
Hubiao
GSK
Tianhe
Wantong Group
Hisamitsu
MUHI
JNJ
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for External Use product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drugs for External Use, with price, sales quantity, revenue, and global market share of Drugs for External Use from 2020 to 2025.
Chapter 3, the Drugs for External Use competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for External Use breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Drugs for External Use market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drugs for External Use.
Chapter 14 and 15, to describe Drugs for External Use sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Drugs for External Use Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Lotion
1.3.3 Ointment
1.3.4 Tincture
1.3.5 Other
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Drugs for External Use Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Drugs for External Use 麻豆原创 Size & Forecast
1.5.1 Global Drugs for External Use Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Drugs for External Use Sales Quantity (2020-2031)
1.5.3 Global Drugs for External Use Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Yunnan Baiyao
2.1.1 Yunnan Baiyao Details
2.1.2 Yunnan Baiyao Major Business
2.1.3 Yunnan Baiyao Drugs for External Use Product and Services
2.1.4 Yunnan Baiyao Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Yunnan Baiyao Recent Developments/Updates
2.2 Linrui
2.2.1 Linrui Details
2.2.2 Linrui Major Business
2.2.3 Linrui Drugs for External Use Product and Services
2.2.4 Linrui Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Linrui Recent Developments/Updates
2.3 Cheezheng
2.3.1 Cheezheng Details
2.3.2 Cheezheng Major Business
2.3.3 Cheezheng Drugs for External Use Product and Services
2.3.4 Cheezheng Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Cheezheng Recent Developments/Updates
2.4 Shengyang Hongyao
2.4.1 Shengyang Hongyao Details
2.4.2 Shengyang Hongyao Major Business
2.4.3 Shengyang Hongyao Drugs for External Use Product and Services
2.4.4 Shengyang Hongyao Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Shengyang Hongyao Recent Developments/Updates
2.5 Yulin
2.5.1 Yulin Details
2.5.2 Yulin Major Business
2.5.3 Yulin Drugs for External Use Product and Services
2.5.4 Yulin Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Yulin Recent Developments/Updates
2.6 Huahong Pharma
2.6.1 Huahong Pharma Details
2.6.2 Huahong Pharma Major Business
2.6.3 Huahong Pharma Drugs for External Use Product and Services
2.6.4 Huahong Pharma Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Huahong Pharma Recent Developments/Updates
2.7 LKF
2.7.1 LKF Details
2.7.2 LKF Major Business
2.7.3 LKF Drugs for External Use Product and Services
2.7.4 LKF Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 LKF Recent Developments/Updates
2.8 Hubiao
2.8.1 Hubiao Details
2.8.2 Hubiao Major Business
2.8.3 Hubiao Drugs for External Use Product and Services
2.8.4 Hubiao Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Hubiao Recent Developments/Updates
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Drugs for External Use Product and Services
2.9.4 GSK Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 GSK Recent Developments/Updates
2.10 Tianhe
2.10.1 Tianhe Details
2.10.2 Tianhe Major Business
2.10.3 Tianhe Drugs for External Use Product and Services
2.10.4 Tianhe Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Tianhe Recent Developments/Updates
2.11 Wantong Group
2.11.1 Wantong Group Details
2.11.2 Wantong Group Major Business
2.11.3 Wantong Group Drugs for External Use Product and Services
2.11.4 Wantong Group Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Wantong Group Recent Developments/Updates
2.12 Hisamitsu
2.12.1 Hisamitsu Details
2.12.2 Hisamitsu Major Business
2.12.3 Hisamitsu Drugs for External Use Product and Services
2.12.4 Hisamitsu Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Hisamitsu Recent Developments/Updates
2.13 MUHI
2.13.1 MUHI Details
2.13.2 MUHI Major Business
2.13.3 MUHI Drugs for External Use Product and Services
2.13.4 MUHI Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 MUHI Recent Developments/Updates
2.14 JNJ
2.14.1 JNJ Details
2.14.2 JNJ Major Business
2.14.3 JNJ Drugs for External Use Product and Services
2.14.4 JNJ Drugs for External Use Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 JNJ Recent Developments/Updates
3 Competitive Environment: Drugs for External Use by Manufacturer
3.1 Global Drugs for External Use Sales Quantity by Manufacturer (2020-2025)
3.2 Global Drugs for External Use Revenue by Manufacturer (2020-2025)
3.3 Global Drugs for External Use Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Drugs for External Use by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Drugs for External Use Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Drugs for External Use Manufacturer 麻豆原创 Share in 2024
3.5 Drugs for External Use 麻豆原创: Overall Company Footprint Analysis
3.5.1 Drugs for External Use 麻豆原创: Region Footprint
3.5.2 Drugs for External Use 麻豆原创: Company Product Type Footprint
3.5.3 Drugs for External Use 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Drugs for External Use 麻豆原创 Size by Region
4.1.1 Global Drugs for External Use Sales Quantity by Region (2020-2031)
4.1.2 Global Drugs for External Use Consumption Value by Region (2020-2031)
4.1.3 Global Drugs for External Use Average Price by Region (2020-2031)
4.2 North America Drugs for External Use Consumption Value (2020-2031)
4.3 Europe Drugs for External Use Consumption Value (2020-2031)
4.4 Asia-Pacific Drugs for External Use Consumption Value (2020-2031)
4.5 South America Drugs for External Use Consumption Value (2020-2031)
4.6 Middle East & Africa Drugs for External Use Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Drugs for External Use Sales Quantity by Type (2020-2031)
5.2 Global Drugs for External Use Consumption Value by Type (2020-2031)
5.3 Global Drugs for External Use Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Drugs for External Use Sales Quantity by Application (2020-2031)
6.2 Global Drugs for External Use Consumption Value by Application (2020-2031)
6.3 Global Drugs for External Use Average Price by Application (2020-2031)
7 North America
7.1 North America Drugs for External Use Sales Quantity by Type (2020-2031)
7.2 North America Drugs for External Use Sales Quantity by Application (2020-2031)
7.3 North America Drugs for External Use 麻豆原创 Size by Country
7.3.1 North America Drugs for External Use Sales Quantity by Country (2020-2031)
7.3.2 North America Drugs for External Use Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Drugs for External Use Sales Quantity by Type (2020-2031)
8.2 Europe Drugs for External Use Sales Quantity by Application (2020-2031)
8.3 Europe Drugs for External Use 麻豆原创 Size by Country
8.3.1 Europe Drugs for External Use Sales Quantity by Country (2020-2031)
8.3.2 Europe Drugs for External Use Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Drugs for External Use Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Drugs for External Use Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Drugs for External Use 麻豆原创 Size by Region
9.3.1 Asia-Pacific Drugs for External Use Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Drugs for External Use Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Drugs for External Use Sales Quantity by Type (2020-2031)
10.2 South America Drugs for External Use Sales Quantity by Application (2020-2031)
10.3 South America Drugs for External Use 麻豆原创 Size by Country
10.3.1 South America Drugs for External Use Sales Quantity by Country (2020-2031)
10.3.2 South America Drugs for External Use Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Drugs for External Use Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Drugs for External Use Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Drugs for External Use 麻豆原创 Size by Country
11.3.1 Middle East & Africa Drugs for External Use Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Drugs for External Use Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Drugs for External Use 麻豆原创 Drivers
12.2 Drugs for External Use 麻豆原创 Restraints
12.3 Drugs for External Use Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Drugs for External Use and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drugs for External Use
13.3 Drugs for External Use Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Drugs for External Use Typical Distributors
14.3 Drugs for External Use Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Yunnan Baiyao
Linrui
Cheezheng
Shengyang Hongyao
Yulin
Huahong Pharma
LKF
Hubiao
GSK
Tianhe
Wantong Group
Hisamitsu
MUHI
JNJ
听
听
*If Applicable.
